Trial site
CTC Clinical Trial Consultants AB
Solna, 171 64, SwedenNot linked to an institution yet
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Phase
- Phase 14 trials
- Phase 24 trials
- Phase 33 trials
- Phase 43 trials
- Status
- Completed7 trials
- Recruiting5 trials
- Active, not recruiting2 trials
- Lead sponsor
- Pfizer3 trials
- Antaros Medical AB1 trial
- AstraZeneca AB1 trial
- Compass Pathfinder Limited1 trial
- Dicot AB1 trial
- and 7 more
Running trials
Recruiting
A study to test the safety and efficacy of RBD1119 given by injection in participants with coronary artery disease
2026-525901-10-00· Phase 2· Ribocure Pharmaceuticals AB· Source
Recruiting
A double-blind, randomised, placebo-controlled first-in-human/Phase Ib trial to investigate safety, tolerability, pharmacokinetics, and preliminary efficacy of single and multiple doses of TIR-C 2% cutaneous emulsion in adults with mild to moderate atopic dermatitis
2026-526343-35-00· Phase 1· Pharmability AB· Source
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
NCT07770841· Phase 3· Novo Nordisk A/S· Source
Recruiting
A positron emission tomography study of synaptic nerve cells proteins alpha-7 nicotinic acetylcholine receptors in brain of healthy volunteers and patients with mild cognitive impairment and Alzheimer´s disease.
2024-515935-31-04· Phase 1· Karolinska Institutet· Source
Recruiting
First-in-human (FIH), microdosing, non-randomized, clinical trial to investigate binding of positron emission tomography tracer [68Ga]Ga-DOTA-Cys-ATH001 targeting platelet derived growth factor receptor β in healthy subjects as compared to patients with metabolic dysfunction-associated steatohepatitis (MASH) and Primary Sclerosing Cholangitis binding (PSC, liver) and patients with fibrostenotic Crohn’s disease (CD, gastrointestinal tract [GI])
2023-506555-15-00· Phase 1· Antaros Medical AB· Source
Recruiting
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet
2023-506150-21-00· Phase 2· Dr. Falk Pharma GmbH· Source
Active, not recruiting
A Phase III study to investigate two initial administrations of COMP360 in treatment-resistant depression
2023-505268-12-00· Phase 3· Compass Pathfinder Limited· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Not yet recruiting
A Trial With EMP16 in Preparation for Late Phase Studies
NCT06993428· Phase 2· Empros Pharma AB· Source
Completed
A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erectile Dysfunction
2024-515065-34-00· Phase 2· Dicot AB· Source
Completed
A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With Renal Impairment Using Positron Emission Tomography (PET)
2024-513143-82-00· Phase 1· AstraZeneca AB· Source
Completed
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
NCT05518123· Phase 4· Pfizer· Source
Completed
Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
NCT05509400· Phase 4· Pfizer· Source
Completed
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
NCT05477524· Phase 3· Pfizer· Source
Completed
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
NCT05452239· Phase 4· H. Lundbeck A/S· Source
Report an error